25/01/2026
FDA and CDC investigate multistate Salmonella outbreak linked to Super Greens supplement; recall underway
Federal officials are investigating Salmonella Typhimurium infections tied to Live it Up-brand Super Greens powder, with 45 cases reported across 21 states. The FDA says the company agreed to a voluntary recall on Jan. 14.
- Published
- Revised

Federal health officials are investigating a multistate outbreak of Salmonella Typhimurium infections linked to a dietary supplement, according to an FDA outbreak update published in mid-January. The product under investigation is Live it Up-brand Super Greens dietary supplement powder, including original and wild berry flavors, with expiration dates ranging from 08/2026 to 01/2028.

In its January 14, 2026 update, the FDA said a total of 45 people infected with the outbreak strain had been reported from 21 states. Illness onset dates ranged from August 22, 2025, to December 30, 2025. Among ill people with information available, many reported consuming the Super Greens supplement before becoming sick; hospitalizations were reported, and no deaths were reported in the update.
The FDA said the supplement was sold primarily online, including via the company’s own website and other online marketplaces. Because distribution is not limited to a single region, the investigation has involved coordination with state and local partners as well as the CDC to track exposures, verify patient histories, and evaluate how the product moved through commerce.
The agency’s consumer guidance is clear: do not eat, sell, or serve the listed Super Greens powders with the identified expiration window. Consumers are advised to throw the product away or return it, and to clean and sanitize surfaces or containers the powder may have touched in order to reduce the risk of cross-contamination.
Salmonella infection can cause diarrhea, fever, and abdominal cramps, and can be especially serious for young children, older adults, and people with weakened immune systems. Because symptoms can overlap with other gastrointestinal illnesses, public-health officials typically encourage people who suspect exposure—particularly those at higher risk—to contact a healthcare provider.
The FDA said its advisory would be updated as additional information becomes available, including whether other products could be implicated. The investigation is also aimed at determining how contamination occurred and whether any upstream ingredients or manufacturing steps played a role—work that can influence both the recall scope and any future enforcement or corrective actions.